Masaru Narabayashi

3.4k citations

96 papers · 2.6k indexed · h-index 28

Oncology top 2%
Pulmonary and Respiratory Medicine top 2%
Radiology, Nuclear Medicine and Imaging top 5%
Radiation top 1%
Molecular Biology

Co-authors: Takashi Mizowaki Yukinori Matsuo Masahiro Hiraoka Yoshiki Norihisa Yasushi Nagata Noriyuki Katsumata Toru Watanabe Kensei Tobinai
Topics: Advanced Radiotherapy Techniques (16 papers)Lung Cancer Diagnosis and Treatment (15 papers)Cancer Treatment and Pharmacology (14 papers)
Cited by: Radiation Oncology Gastroenterology
Journals: Journal of Clinical Oncology British Journal of Cancer International Journal of Radiation Oncology*Biology*Physics
Partner nations: Japan United States United Kingdom

In The Last Decade

Masaru Narabayashi

94 papers receiving 2.6k citations

Peers

Countries citing papers authored by Masaru Narabayashi

Since Specialization

Citations

This map shows the geographic impact of Masaru Narabayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaru Narabayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaru Narabayashi more than expected).

Fields of papers citing papers by Masaru Narabayashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaru Narabayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaru Narabayashi. The network helps show where Masaru Narabayashi may publish in the future.

Co-authorship network of co-authors of Masaru Narabayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Masaru Narabayashi. A scholar is included among the top collaborators of Masaru Narabayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaru Narabayashi. Masaru Narabayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Incidence and Risk Factors of Symptomatic Radiation Pneumonitis in Non–Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy and Consolidation Durvalumab 2021 ·Clinical Lung Cancer ·Takashi Shintani,(unknown),Yukinori Matsuo,Masakazu Ogura,Takamasa Mitsuyoshi,Norio Araki,Kota Fujii,(unknown),Kiyoshi Nakamatsu,Takahiro Kishi,(unknown),Takashi Sakamoto,Masaru Narabayashi,(unknown),Masato Sakamoto,(unknown),(unknown),Young Hak Kim,Takashi Mizowaki	34
2	Treatment of opioid-induced constipation with naldemedine in patients with cancer: onset of action in a randomized phase 3 trial 2016 ·Annals of Oncology ·(unknown),Nobuyuki Katakami,Toshiyuki Harada,Katsunori Shinozaki,Masahiro Tsutsumi,(unknown),(unknown),(unknown),Masaru Narabayashi,Narikazu Boku	4
3	Radiosensitivity of pimonidazole-unlabelled intratumour quiescent cell population to γ-rays, accelerated carbon ion beams and boron neutron capture reaction 2013 ·British Journal of Radiology ·(unknown),(unknown),Hiroki Tanaka,Ryoichi Hirayama,Yoshitaka Matsumoto,Akiko Uzawa,Minoru Suzuki,Natsuko Kondo,Masaru Narabayashi,Akira Maruhashi,Koji Ono	12
4	A phase II study of lapatinib for brain metastases in patients with HER2-overexpressing breast cancer following trastuzumab based systemic therapy and cranial radiotherapy: subset analysis of Japanese patients 2012 ·International Journal of Clinical Oncology ·Hiroji Iwata,Masaru Narabayashi,Yoshinori Ito,Shigehira Saji,Yasuhiro Fujiwara,(unknown),(unknown),Yasutsuna Sasaki	16
5	Differences in the dose-volume metrics with heterogeneity correction status and its influence on local control in stereotactic body radiation therapy for lung cancer 2012 ·Journal of Radiation Research ·N. Ueki,Yukinori Matsuo,Keiko Shibuya,Mitsuhiro Nakamura,Masaru Narabayashi,Katsuyuki Sakanaka,Yoshiki Norihisa,Takashi Mizowaki,(unknown)	10
6	Psychological Distress of the Bereaved Seeking Medical Counseling at a Cancer Center 2012 ·Japanese Journal of Clinical Oncology ·M. Ishida,Hideki Onishi,(unknown),Yukio Tada,Hiroshi Ito,Masaru Narabayashi,Yusuke Sasaki,Shinobu Nomura,Yosuke Uchitomi	14
7	Drug-induced akathisia as a cause of distress in spouse caregivers of cancer patients 2011 ·Palliative & Supportive Care ·(unknown),(unknown),Hiroshi Ito,Makoto Wada,(unknown),Yukio Tada,M. Ishida,Keiko Mizuno,(unknown),Masaru Narabayashi,Yumi Iwamitsu,Hideki Onishi	2
8	First clinical pharmacokinetic dose-escalation study of sagopilone, a novel, fully synthetic epothilone, in Japanese patients with refractory solid tumors 2011 ·Investigational New Drugs ·Kazuhiro Araki,(unknown),Hirofumi Mukai,Toru Mukohara,Keiji Kodama,Yukio Ando,Masaru Narabayashi,Hironobu Minami,Kiyomi Mera,Yasutsuna Sasaki	3
9	Effect of Audio Coaching on Correlation of Abdominal Displacement With Lung Tumor Motion 2009 ·International Journal of Radiation OncologyBiologyPhysics ·Mitsuhiro Nakamura,Yuichiro Narita,Yukinori Matsuo,Masaru Narabayashi,Manabu Nakata,Akira Sawada,Takashi Mizowaki,Yasushi Nagata,Masahiro Hiraoka	21
10	Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer 2009 ·Cancer Chemotherapy and Pharmacology ·Ken‐ichi Fujita,Yukio Ando,Wataru Yamamoto,Toshimichi Miya,Hisashi Endo,Yu Sunakawa,Kazuhiro Araki,Keiji Kodama,Fumio Nagashima,Wataru Ichikawa,Masaru Narabayashi,Yuko Akiyama,Kaori Kawara,(unknown),Hiroyasu Ogata,Hiroyasu Iwasa,Yasushi Okazaki,Takashi Hirose,Yasutsuna Sasaki	82
11	Activation syndrome caused by paroxetine in a cancer patient 2008 ·Palliative & Supportive Care ·Tomomi Nishida,Makoto Wada,(unknown),Hiroshi Ito,Masaru Narabayashi,Hideki Onishi	4
12	A case of respiratory akathisia in a cancer patient: A case report 2008 ·Palliative & Supportive Care ·Yu Sunakawa,Makoto Wada,Tomomi Nishida,(unknown),Kazuhiro Araki,Hisashi Endo,Fumio Nagashima,Wataru Ichikawa,Toshimichi Miya,Hideki Onishi,Masaru Narabayashi,Yasutsuna Sasaki	3
13	Phase III study to evaluate the use of high‐dose chemotherapy as consolidation of treatment for high‐risk postoperative breast cancer: Japan Clinical Oncology Group study, JCOG 9208 2007 ·Cancer Science ·Yutaka Tokuda,Tomoo Tajima,Masaru Narabayashi,Kunihiko Takeyama,Toru Watanabe,Takashi Fukutomi,Takaaki Chou,Muneaki Sano,Tadahiko Igarashi,Yasutsuna Sasaki,Michinori Ogura,Shigeto Miura,Shinichiro Okamoto,Masami Ogita,Masaharu Kasai,Tadashi Kobayashi,Haruhiko Fukuda,Shigemitsu Takashima,Kensei Tobinai,(unknown)	19
14	Novel Single Nucleotide Polymorphism of UGT1A9 Gene in Japanese 2006 ·Drug Metabolism and Pharmacokinetics ·Ken‐ichi Fujita,Yukio Ando,Fumio Nagashima,Wataru Yamamoto,Hisashi Endo,Keiji Kodama,Kazuhiro Araki,Toshimichi Miya,Masaru Narabayashi,Yasutsuna Sasaki	6
15	Pharmacogenetic impact of polymorphisms in the coding region of the UGT1A1 gene on SN‐38 glucuronidation in Japanese patients with cancer 2006 ·Cancer Science ·Kazuhiro Araki,Ken‐ichi Fujita,Yukio Ando,Fumio Nagashima,Wataru Yamamoto,Hisashi Endo,Toshimichi Miya,Keiji Kodama,Masaru Narabayashi,Yasutsuna Sasaki	76
16	Cardiac conduction abnormalities in patients with breast cancer undergoing high-dose chemotherapy and stem cell transplantation 2000 ·Bone Marrow Transplantation ·Masashi Ando,(unknown),J. Sawada,Yoichi Takaue,Kazuto Togitani,(unknown),Masaru Narabayashi,K Takeyama,Ryuji Tanosaki,Shin Mineishi,Yukio Kobayashi,Toru Watanabe,I Adachi,Kensei Tobinai	20
17	Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma 1998 ·Annals of Oncology ·Kensei Tobinai,Yukio Kobayashi,Masaru Narabayashi,Michinori Ogura,Yoshitoyo Kagami,Y Morishima,T. Ohtsu,Tomofumi Igarashi,Yosuke Sasaki,T. Kinoshita,Takashi Murate	126
18	Prognostic Factors and a Predictive Model of Follicular Lymphoma: A 25-year Study at a Single Institution in Japan 1996 ·Japanese Journal of Clinical Oncology ·Noriyuki Katsumata,Yoshihiro Matsuno,H. Nakayama,T Takenaka,Yukio Kobayashi,K Takeyama,Masaru Narabayashi,Takashi Fukushima,(unknown),(unknown),Kinuko Tajima,Hiroshi Ikeda,Kensei Tobinai	13
19	A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer 1996 ·British Journal of Cancer ·I Adachi,Toru Watanabe,S Takashima,Masaru Narabayashi,N Horikoshi,Hideaki Aoyama,T Taguchi	78
20	Immunohistological study in the distribution and function of follicular dendritic cell(FDC) in follicular lymphoma. 1990 ·Masaru Narabayashi,Kunihiko Maeda,Mikio Matsuda,Yutaka Imai	1

About Masaru Narabayashi

Masaru Narabayashi is a scholar working on Radiation, Oncology and Gastroenterology, having authored 96 papers that have together received 2.6k indexed citations. Recurring topics across this work include Advanced Radiotherapy Techniques (16 papers), Lung Cancer Diagnosis and Treatment (15 papers) and Cancer Treatment and Pharmacology (14 papers). The work is most often cited by research in Radiation (460 citations), Oncology (1.0k citations) and Gastroenterology (177 citations). Masaru Narabayashi has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Takashi Mizowaki, Yukinori Matsuo, Masahiro Hiraoka, Yoshiki Norihisa, Yasushi Nagata, Noriyuki Katsumata, Toru Watanabe, Kensei Tobinai, Masashi Ando and Yasutsuna Sasaki. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact